NervGen Pharma Financial Overview
NervGen Pharma's market cap is currently $355.01M. The company's EPS TTM is $-0.04349604; its P/E ratio is -17.45; NervGen Pharma is scheduled to report earnings on November 24, 2025, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
